GILD - GILEAD SCIENCES, INC.
111.44
-1.910 -1.714%
Share volume: 8,638,934
Last Updated: 03-14-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$113.35
-1.91
-0.02%
Summary score
49%
Profitability
32%
Dept financing
34%
Liquidity
9%
Performance
81%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
4.21%
Return on assets
3.15%
Return on sales
28.87%
Return on invested capital
2.16%
Total debt ratio
67.37%
Debt ratio change over timeo
116.87%
Current Ratio
1.3%
Quick Ratio
1.15%
Cash Position Ratio
0.55%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-23.78%
Return on assets
1.4%
Return on sales
10.21%
Return on invested capital
-14.26%
Total debt ratio
67.38%
Debt ratio change over timeo
8.62%
Current Ratio
1.23%
Quick Ratio
1.08%
Cash Position Ratio
0.47%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
4.1%
Return on sales
32.4%
Return on invested capital
0%
Total debt ratio
67.23%
Debt ratio change over time
0%
Current Ratio
1.6%
Quick Ratio
1.45%
Cash Position Ratio
0.83%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
15.22%
Return on assets
639.62%
Return on sales
6990.73%
Return on invested capital
-44.29%
Total debt ratio
11686.91%
Debt ratio change over time
116.87%
Current Ratio
247.89%
Quick Ratio
218.72%
Cash Position Ratio
104.36%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GILD | AMGN | BIIB | BNTX |
|---|---|---|---|---|
| Return on equity | 4.21% | 18.63% | 3.82% | 16.49% |
| Return on assets | 3.15% | 3.07% | 2.36% | 15.3% |
| Return on sales | 28.87% | 30.43% | 24.63% | 7.81% |
| Return on invested capital | 2.16% | 5.33% | 3.93% | -56.8% |
| Profitability | 45% | 80% | 48% | 54% |
| Total debt ratio | 67.37% | 92.23% | 47.08% | 20.78% |
| Debt ratio change over time | 116.87% | 18.13% | 2.96% | -1.18% |
| Dept financing | 43% | 29% | 13% | 6% |
| Current Ratio | 1.23% | 1.32% | 1.9% | 11.38% |
| Quick Ratio | 1.08% | 0.95% | 1.22% | 11.16% |
| Cash Position Ratio | 0.47% | 0.47% | 0.44% | 5.59% |
| Liquididy | 13% | 17% | 20% | 75% |
| Short-term ratios | GILD | AMGN | BIIB | BNTX |
|---|---|---|---|---|
| Return on equity | -23.78% | 0% | 3.13% | -1.58% |
| Return on assets | 1.4% | 2.13% | 2.16% | -2.3% |
| Return on sales | 10.21% | 21.39% | 24.36% | -272.71% |
| Return on invested capital | -14.26% | 0% | 2.94% | -13.26% |
| Profitability | 27% | 47% | 100% | 0% |
| Total debt ratio | 67.38% | 93.35% | 41.59% | 10.28% |
| Debt ratio change over time | 8.62% | 0% | 18.48% | -0.69% |
| Dept financing | 30% | 25% | 36% | 3% |
| Current Ratio | 1.23% | 1.32% | 1.9% | 11.38% |
| Quick Ratio | 1.08% | 0.95% | 1.22% | 11.16% |
| Cash Position Ratio | 0.47% | 0.47% | 0.44% | 5.59% |
| Liquididy | 7% | 7% | 9% | 75% |